Tempris named Company of the Year for wireless temperature sensor innovations

Holzkirchen, Bavaria, Germany: Pharma Tech Outlook magazine has named Tempris its ‘Company of the Year for 2023’ in honor of its revolutionary work in pioneering wireless temperature monitoring technology for the pharmaceutical industry.

The leading edge Tempris wireless and battery-free temperature monitoring sensor system empowers pharmaceutical companies to achieve a more reliable and robust manufacturing processes, particularly in demanding high precision applications such as freeze-drying (lyophilization). It also simplifies formulation development and regulatory filing processes, maximizing efficiency and minimizing development costs, for cycle optimization and shorter time to market.

Solutions delivered

From first concept some five years ago, Tempris has succeeded in developing systems that deliver accurate, real-time temperature readings within various product containers during lyophilization, ensuring compliance with Good Manufacturing Practice (GMP) regulations and enhancing reliability and data integrity. The company is committed to pioneering advancements in freeze-drying applications, offering globally adaptable and efficient solutions for companies venturing into this challenging but highly necessary domain.

Its latest-generation sensors are designed for complete automation in sterile drug production. A camera captures the sensor’s QR code, enabling automatic recognition and traceability during the process.

High adaptability

The highly adaptable Tempris technology supports all types of primary packaging like vials, syringes, trays, and bulks, especially vials and syringes with low filling volume due to the optimization of geometry and size. The new design also focuses on implementing single-use concepts to suit niche applications, such as cytostatics.

In its decision to name Tempris as Top Pharma Manufacturing Solutions Provider for 2023, the magazine’s judging panel also considered Tempris’s collaborations with leading names in the pharma industry and academia, as well as its also recent introduction of software allowing easy visualization of real time temperature measurement data in 3D. Tempris creates a digital twin of production machines with freely configurable sensor placement for identifying hot and cold spots. Users can read measurement data at desired points and analyze the freeze-drying process by replaying data in fast motion. This allows users to optimize sensor position and distribution in the lyophilization system qualification (PQ) process.

About Tempris

Founded in 2008 and based at Holzkirchen in Bavaria, Tempris GmbH has become a leading innovator in real-time temperature measurement and monitoring. Its revolutionary wireless and battery-free quartz-based temperature sensors and software form the basis for a Process Analytical Technology (PAT) tool to streamline lyophilization processes by providing real-time, accurate, and reliable temperature data of unparalleled accuracy and reliability.

The Tempris brand strapline: ‘Easify your Lyo Process’ encapsulates its mission to automate and optimize freeze-drying processes by enabling real-time product temperature monitoring during process. It is collaborating with academia and leading names in the industry to apply this technological advance to unlock full automation and major productivity gains in lyophilization.

Tempris has developed product and service streams in development & manufacturing, process control applications, software development, and implementation support.

From its headquarters south of Munich, Tempris has added distribution partners in Europe, Asia and the USA and has become ISO 9001 certified for quality management systems, as well as ISO 14001 for environmental management and sustainability, with all products designed and engineered to comply with applicable regulations, such as GAMP 5 guidelines and FDA 21 CFR Part 11 / EU GMP Annex 11 for compliance of IT systems.

Learn more at: https://www.tempris.com

Resources

Click on News from Tempris for further information.